FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376271311> ?p ?o ?g. }

• W4376271311 endingPage "508" @default.
• W4376271311 startingPage "499" @default.
• W4376271311 abstract "Objective Paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs) and opiates/opioids, administered parenterally via intravenous or intramuscular route, are widely used to provide analgesia for patients with moderate to severe pain. This systematic review and meta-analysis evaluated the level of analgesia provided by intravenous paracetamol (IVP) alone compared with NSAIDs (intravenous or intramuscular), or opioids (intravenous) alone in adults attending the ED with acute pain. Methods Two authors independently searched PubMed (MEDLINE), Web of Science, Embase (OVID), Cochrane Library, SCOPUS and Google Scholar (3 March 2021–20 May 2022) for randomised trials without any language or date restriction. Clinical trials were evaluated using the Risk of Bias V.2 tool. The primary outcome was mean difference (MD) for pain reduction at 30 min (T30) post analgesia delivery. The secondary outcomes were MD in pain reduction at 60, 90 and 120 min; the need for rescue analgesia; and the occurrence of adverse events (AEs). Results Twenty-seven trials (5427 patients) were included in the systematic review and 25 trials (5006 patients) in the meta-analysis. There was no significant difference in pain reduction at T30 between the IVP group and opioids (MD −0.13, 95% CI −1.49 to 1.22) or IVP and NSAIDs (MD −0.27, 95% CI −1.0 to 1.54. There was also no difference at 60 min, IVP group versus opioid group (MD −0.09, 95% CI −2.69 to 2.52) or IVP versus NSAIDs (MD 0.51, 95% CI 0.11 to 0.91). The quality of the evidence using Grading of Recommendations, Assessments, Development and Evaluations methodology was low for MD in pain scores. The need for rescue analgesia at T30 was significantly higher in the IVP group compared with the NSAID group (risk ratio (RR): 1.50, 95% CI 1.23 to 1.83), with no difference found between the IVP group and the opioid group (RR: 1.07, 95% CI 0.67 to 1.70). AEs were 50% lower in the IVP group compared with the opioid group (RR: 0.50, 95% CI 0.40 to 0.62), whereas no difference was observed in the IVP group compared with the NSAID group (RR: 1.30, 95% CI 0.78 to 2.15). Conclusion In patients presenting to the ED with a diverse range of pain conditions, IVP provides similar levels of pain relief compared with opiates/opioids or NSAIDs at T30 post administration. Patients treated with NSAIDs had lower risk of rescue analgesia, and opioids cause more AEs, suggesting NSAIDs as the first-choice analgesia and IVP as a suitable alternative. PROSPERO registration number CRD42021240099." @default.
• W4376271311 created "2023-05-13" @default.
• W4376271311 creator A5051182659 @default.
• W4376271311 creator A5053921290 @default.
• W4376271311 creator A5059783474 @default.
• W4376271311 creator A5078663698 @default.
• W4376271311 creator A5079662132 @default.
• W4376271311 creator A5083916565 @default.
• W4376271311 date "2023-05-12" @default.
• W4376271311 modified "2023-09-27" @default.
• W4376271311 title "Comparison of intravenous paracetamol (acetaminophen) to intravenously or intramuscularly administered non-steroidal anti-inflammatory drugs (NSAIDs) or opioids for patients presenting with moderate to severe acute pain conditions to the ED: systematic review and meta-analysis" @default.
• W4376271311 cites W1883643540 @default.
• W4376271311 cites W1981865987 @default.
• W4376271311 cites W1992249310 @default.
• W4376271311 cites W2001973406 @default.
• W4376271311 cites W2047696659 @default.
• W4376271311 cites W2057556593 @default.
• W4376271311 cites W2070442907 @default.
• W4376271311 cites W2073115649 @default.
• W4376271311 cites W2082369656 @default.
• W4376271311 cites W2097561978 @default.
• W4376271311 cites W2097589179 @default.
• W4376271311 cites W2098186070 @default.
• W4376271311 cites W2138285966 @default.
• W4376271311 cites W2142351241 @default.
• W4376271311 cites W2150487875 @default.
• W4376271311 cites W2163127949 @default.
• W4376271311 cites W2255243419 @default.
• W4376271311 cites W2291862107 @default.
• W4376271311 cites W2298227553 @default.
• W4376271311 cites W2310456761 @default.
• W4376271311 cites W2321378115 @default.
• W4376271311 cites W2586327237 @default.
• W4376271311 cites W2628771359 @default.
• W4376271311 cites W2724211673 @default.
• W4376271311 cites W2738897389 @default.
• W4376271311 cites W2756454190 @default.
• W4376271311 cites W2770301977 @default.
• W4376271311 cites W2777686971 @default.
• W4376271311 cites W2793654944 @default.
• W4376271311 cites W2811473826 @default.
• W4376271311 cites W2886450689 @default.
• W4376271311 cites W2911830490 @default.
• W4376271311 cites W2913348151 @default.
• W4376271311 cites W2950076271 @default.
• W4376271311 cites W3024777207 @default.
• W4376271311 cites W3037883546 @default.
• W4376271311 cites W3093211812 @default.
• W4376271311 cites W3114406448 @default.
• W4376271311 cites W4211061761 @default.
• W4376271311 cites W4306639550 @default.
• W4376271311 doi "https://doi.org/10.1136/emermed-2022-212869" @default.
• W4376271311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37173122" @default.
• W4376271311 hasPublicationYear "2023" @default.
• W4376271311 type Work @default.
• W4376271311 citedByCount "0" @default.
• W4376271311 crossrefType "journal-article" @default.
• W4376271311 hasAuthorship W4376271311A5051182659 @default.
• W4376271311 hasAuthorship W4376271311A5053921290 @default.
• W4376271311 hasAuthorship W4376271311A5059783474 @default.
• W4376271311 hasAuthorship W4376271311A5078663698 @default.
• W4376271311 hasAuthorship W4376271311A5079662132 @default.
• W4376271311 hasAuthorship W4376271311A5083916565 @default.
• W4376271311 hasConcept C126322002 @default.
• W4376271311 hasConcept C168563851 @default.
• W4376271311 hasConcept C170493617 @default.
• W4376271311 hasConcept C197934379 @default.
• W4376271311 hasConcept C2776478404 @default.
• W4376271311 hasConcept C2778722691 @default.
• W4376271311 hasConcept C2780820201 @default.
• W4376271311 hasConcept C2781063702 @default.
• W4376271311 hasConcept C2993997175 @default.
• W4376271311 hasConcept C42219234 @default.
• W4376271311 hasConcept C535046627 @default.
• W4376271311 hasConcept C71924100 @default.
• W4376271311 hasConcept C95190672 @default.
• W4376271311 hasConceptScore W4376271311C126322002 @default.
• W4376271311 hasConceptScore W4376271311C168563851 @default.
• W4376271311 hasConceptScore W4376271311C170493617 @default.
• W4376271311 hasConceptScore W4376271311C197934379 @default.
• W4376271311 hasConceptScore W4376271311C2776478404 @default.
• W4376271311 hasConceptScore W4376271311C2778722691 @default.
• W4376271311 hasConceptScore W4376271311C2780820201 @default.
• W4376271311 hasConceptScore W4376271311C2781063702 @default.
• W4376271311 hasConceptScore W4376271311C2993997175 @default.
• W4376271311 hasConceptScore W4376271311C42219234 @default.
• W4376271311 hasConceptScore W4376271311C535046627 @default.
• W4376271311 hasConceptScore W4376271311C71924100 @default.
• W4376271311 hasConceptScore W4376271311C95190672 @default.
• W4376271311 hasIssue "7" @default.
• W4376271311 hasLocation W43762713111 @default.
• W4376271311 hasLocation W43762713112 @default.
• W4376271311 hasOpenAccess W4376271311 @default.
• W4376271311 hasPrimaryLocation W43762713111 @default.
• W4376271311 hasRelatedWork W2007985871 @default.
• W4376271311 hasRelatedWork W2294106333 @default.
• W4376271311 hasRelatedWork W2381982637 @default.
• W4376271311 hasRelatedWork W2794438779 @default.

• next